Navigation Links
Centage Corporation Reports 16% Growth in 2009; Planning Maestro, Business Performance Management Software Implementations on the Rise
Date:1/18/2010

Centage marks 16% increase in revenue growth and 20% increase in unit sales over 2008; notes strong momentum of Planning Maestro, business performance management software, implementations

Natick, Mass. (PRWEB) January 18, 2010 -- Centage Corporation, a leading provider of integrated budgeting, forecasting, consolidation and financial reporting solutions for small to mid-sized companies today announced an impressive 16% increase in revenue, coupled with a 20% increase in unit sales, over 2008 for 2009. This marks the company's 8th year of consecutive double-digit growth in revenue year-over-year. The company continued to add new clients at a strong pace in the healthcare, manufacturing, software and not-for-profit industries as well as clocking over 70 implementations of its latest business performance management solution, Planning Maestro®, since August 2009. Centage now enjoys a solid customer base of over 1800 clients worldwide with over 9,000 licensed users.

Centage's financial management solutions, are the next logical step for small to mid-sized businesses that want to migrate off error-prone, inflexible spreadsheet models and take advantage of automation for real-time updates, budget consolidation, powerful calculation engine and precise, integrated Income Statement, Balance Sheet and Statement of Cash Flows on-demand. Customers report up to a 50% reduction in their planning cycle, accurate formula calculations and 100% alignment with their accounting/ERP system for accurate variance reporting and analysis.

Centage financial management solutions include:

Budget Maestro - ideal for the small to mid-size company team that requires an easy to use, cost-effective integrated budgeting, forecasting, consolidation and financial reporting for 1-10 users. Packed with numerous pre-built capabilities, Budget Maestro implementations typically take about 8 hours. The software installs in less than 10 minutes with no or little IT support required to get up and running.

Planning Maestro - ideal for the mid-market enterprise that requires a more robust, Business Performance Management (BPM ) solution incorporating driver-based planning, dynamic forecasting, automated workflow and multi-dimensional financial and management reporting. Powerful modeling capabilities enable the finance team to analyze the business from multiple perspectives to aid in spotting opportunities or areas of improvement. Pre-built templates and menus easily guide budget contributors through the planning process in record time. Planning Maestro is an attractive alternative to high-end business performance management solutions for a fraction of the cost eliminating the long implementation cycle and big consulting fee. Planning Maestro implementations typically range between 24-30 hours.

"The secret to our success in 2009 was simple" says Kamran Sassoon, President and CEO of Centage. "We provided exceptional value to small and mid-sized businesses by providing feature-rich, easy-to-use financial management solutions to help them achieve their goals of reducing costs and improving productivity in response to an uncertain economic climate. We work side-by-side with our customers every day to ensure they get the most benefit out of what our solutions provide."

Fully functional versions of Budget Maestro and Planning Maestro are available for a free evaluation for 30 days. Visit www.centage.com to learn more. Budget Maestro and Planning Maestro solutions are available directly from Centage Corporation and through Centage authorized resellers.

About Centage Corporation
Centage Corporation provides sophisticated yet easy-to use Business Performance Management solutions that enable organizations of all sizes to improve their budgeting, forecasting, consolidation and reporting capabilities. Since 1996, thousands of licenses of the company's premier financial solution, Budget Maestro® and Planning Maestro®, have been sold worldwide, enabling managers at all levels to dramatically simplify their budgeting process and improve the accuracy and efficiency of their overall business planning process. The Maestro family of solutions by Centage delivers superior ROI through a combination of best price, easiest implementation and use, and a fiscally sound methodology that enables confident decision-making. Centage Corporation is headquartered in Natick, MA. For more information visit www.centage.com or call 800.366.5111.

###

Read the full story at http://www.prweb.com/releases/2010/01/prweb3451824.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Quick Medical to Donate a Percentage of Internet Sales to Charity
2. Significantly Higher Percentage of Hetastarch Recipients Underwent a Surgical Procedure Than Those Receiving Albumin/Plasma Protein Fraction
3. Drivewear(R) Technology Helps Combat Growing Percentage of Traffic Accidents Caused by Driving Distractions
4. Hepregen Corporation Receives SBIR Phase II Grant from the National Science Foundation and Presents Corporate Update at OneMed Forum
5. United American Healthcare Corporation Announces Meeting Date and Record Date for Annual Meeting of Shareholders
6. Amerigroup Corporation to Discuss Fourth Quarter and 2009 Year-End Earnings on February 19
7. Providence Service Corporation Comments on Senate Health Care Reform
8. Triple-S Management Corporation to Present at J. P. Morgan Healthcare Conference
9. Service Corporation International Extends Offer for Keystone North America Inc.
10. Atrion Networking Corporation Selects Ruckus Wireless for Reliable as Wire Enterprise Wi-Fi Service
11. Corporations, Universities and State Governments Deploy Thomson Reuters Solution to Improve Employees Benefit Selection Process
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Centage Corporation Reports 16% Growth in 2009;  Planning Maestro, Business Performance Management Software Implementations on the Rise 
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease Report®, which ... participating in Rare Disease Day events, hosted by the Rare Disease Legislative Advocates ... a website, weekly e-newsletter and quarterly publication, will be conducting interviews with patients ...
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael ... “Mama June: From Not to Hot,” which will begin airing on February 24, 2017. ... to millions from the 2012 reality television series, “Here Comes Honey Boo Boo.” The ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... thought leadership , media relations, content marketing, social media management, corporate communications, SEO ... already in the state and in nearby New Hampshire, Massachusetts and Canada, Rosica ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... will host a diverse symposium on “Doping in Sport: How the Culture ... Mullin Richter & Hampton LLP. The symposium will be held at Pepperdine University ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig Publishing ... generations converge and explore the world from different perspectives. By providing a place ... to gain understanding, increase empathy, and find greater happiness. , "Our approach ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Feb. 23, 2017  This report analyzes the worldwide ... following Products: Intermediates, Analytical, and Others. ... include Pharmaceuticals, and Agrochemicals. The report provides separate comprehensive ... Europe , and Rest of World. ... 2015 through 2022. Also, a six-year historic analysis is ...
(Date:2/24/2017)... YORK , Feb. 23, 2017  The ... 330.6 million by 2021 from USD 275.9 million ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... increasing spending on pharmaceutical R&D, and growth in ... driving the market growth for particle counters. On ...
(Date:2/24/2017)... -- Xynomic Pharmaceuticals, Inc., an oncology drug research and ... exclusive worldwide rights to develop, manufacture and commercialize ... hematological and solid tumors. To date ... clinical trials of Abexinostat in US, EU and ... completed, demonstrating that Abexinostat is clinically active in ...
Breaking Medicine Technology: